INSTANT-VIEW® H. pylori Rapid Test is a rapid qualitative immunoassay intended to detect the presence of IgG antibodies specific to Helicobacter pylori (H. pylori) in human whole blood. The test provides an aid in the diagnosis of H. pylori infection and is for use by health care professionals only.
This device provides a presumptive result and should be used in conjunction with patient’s symptoms and physician’s other diagnostic results.
Helicobacter pylori has been associated with a variety of gastrointestinal diseases.1-3 H. pylori infections occur in human populations throughout the world. In developed countries, about 50% of the population may have H. pylori infection by the age of 60 years, while only 10-20% of adults in the third decade of life have it.1, 2
Positive Percent Agreement - 97.9%
Negative Percent Agreement: 97.4%
- 25 Test devices/kit, each device is sealed in a pouch with a disposable dropper.
- 1 Bottle of Wash Buffer containing 7 ml PBS solution with 0.02% sodium azide as a preservative.
- 1 Package Insert (Instruction for Use).
- 1 Kit Contents Sheet
INSTANT-VIEW® H. pylori Rapid Test is a rapid qualitative immunoassay intended to detect the presence of IgG antibodies specific to Helicobacter pylori (H. pylori) in human whole blood. The test provides an aid in the diagnosis of H. pylori infection and is for use by health care professionals only.
This device provides a presumptive result and should be used in conjunction with patient’s symptoms and physician’s other diagnostic results.
Helicobacter pylori has been associated with a variety of gastrointestinal diseases.1-3 H. pylori infections occur in human populations throughout the world. In developed countries, about 50% of the population may have H. pylori infection by the age of 60 years, while only 10-20% of adults in the third decade of life have it.1, 2
Positive Percent Agreement - 97.9%
Negative Percent Agreement: 97.4%
- Marchall, BJ, McGechie, DB, Rogers, PAR and Glancy, RG. Pyloric
Campylobacter infection and gastroduodenal disease. Med. J. Australia. 149: 439-44: 1985. - Soll, AH. Pathogenesis of peptic ulcer and implications for therapy. New Engl. J. Med. 322:909-916:1990.
- Parsonnet, J, Freidman, GD Vundersteen, DP, Chang, Y, Vogelman, JH, Orentreigh, N and Sibley, RK. Helicobacter pylori infection and the risk of gastric carcinoma. New Engl. J. Med. 325: 1127-31; 1991.
- Marshall, BJ, Warren, JR and Blincow, ED. Prospective double blind trial of duodenal ulcer relapse after Geradication of Campylobacter pylori. Lancet. December 1437-42; 1988.
- Graham, DY et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Annals of Internal Med. 116: 705; 1992.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.
Canada